Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease

Trial Profile

Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Etanercept (Primary) ; Methotrexate; Prednisolone
  • Indications Behcet's syndrome; Posterior uveitis; Retinal vascular occlusion
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Aug 2011 New source identified and integrated (Iranian Registry of Clinical Trials; IRCT138901292641N2).
    • 20 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top